Real-World Evidence
Reimagining the possibilities of evidence generation
We’re leading a vision of integrated evidence, harnessing new approaches to evidence generation through our engaged care network and fit-for-purpose scientific methods and tools. Find out how we advance our understanding of cancer treatment through robust insights across R&D and commercialization.
Why the leading global life sciences companies work with Flatiron
- Engaged care network
Every day, community clinics and academic medical centers rely on Flatiron to power smarter care. With Flatiron technology integrated directly at the source – we’ve built the foundation for high quality evidence generation to enable industry-leading research.
- Global regulatory experience
Working with our biopharma partners, we have supported briefing packages in the U.S., Europe and Asia. And today, Flatiron evidence is increasingly used in submissions to the FDA, EMA and PMDA and post-marketing requirements.
- Learning from real-world experience
We offer 22 disease-specific and disease-agnostic datasets with deep clinical, genomic and outcomes variables. Leveraging new approaches to evidence generation, we’re now seamlessly integrating clinical research and insight generation into everyday care.
- Fit-for-purpose scientific methods and solutions
We offer customized datasets, expert analytic and regulatory services, and solutions tailored to answer targeted research questions.
- Expertise at every stage of the life cycle
From oncologists to quantitative scientists and regulatory affairs experts, our people have a track record of delivering industry firsts throughout the drug life cycle.
- Featured in 560+ peer-reviewed publications and conference presentations
Our real-world evidence powers research published in the world’s leading peer-reviewed scientific journals. Flatiron’s publication record reflects our deep industry partnerships and commitment to advancing scientific methods.
Advancing the use of RWE with our research collaborators
Generate real-world evidence across the life cycle of a drug, pre- and post-launch
Flatiron real-world data has informed key clinical development decisions, supported clinical trial data in regulatory submissions, fulfilled post-marketing commitments, and enabled market access and payer decisions.
Our products
The world’s leading biopharma companies use Flatiron real-world data products to accelerate R&D and access, make research more inclusive, and drive transformative cancer care.
Enhanced Datamart
Our foundational data subscriptions, covering 22 tumor types, deliver a wide pool of clinical data sourced from electronic health records reflecting patients’ journeys from diagnosis onward.
Clinico-Genomic Database
Real-world Clinico-Genomic Database (CGDB) integrating clinical data curated from electronic health records with comprehensive genomic profiling data for patients in the Flatiron network who are tested with a Foundation Medicine assay.
Spotlight Custom Solutions
Spotlight projects provide fit-for-purpose data, building on our subscription offerings, and expertise tailored to answer our partners specific research questions.
Integrated evidence
Enhance data depth and longitudinality with integrated evidence, which thoughtfully combines real-world data from different sources. Flatiron can link patient-level EHR data with genomics, imaging or claims data.
Linked EHR and Genomics Data
Flatiron Health and Foundation Medicine’s Clinico-Genomics Database for disease-specific and disease-agnostic analyses.
Linked EHR and Radiology Imaging Data
Datasets that link radiology images (DICOM) with Flatiron’s EHR-derived clinical and outcomes data for disease-specific and disease-agnostic analyses.
Linked EHR and Claims Data
A real-world linked EHR-Claims data solution that is de-identified and ready for use, unlocking the full patient journey.
